Patient-reported outcomes in drug safety evaluation

被引：17

作者：

Basch, E. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Grp, New York, NY 10021 USA

来源：

ANNALS OF ONCOLOGY | 2009年 / 20卷 / 12期

关键词：

QUALITY-OF-LIFE; UNITED-STATES; SYMPTOMS; CHEMOTHERAPY; ONCOLOGY;

D O I：

10.1093/annonc/mdp542

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1905 / 1906

页数：2

共 20 条

[1] DRUG DISCONTINUATIONS IN THE UNITED-KINGDOM AND THE UNITED-STATES, 1964 TO 1983 - ISSUES OF SAFETY [J].

BAKKE, OM ;

WARDELL, WM ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (05) :559-567

[2]

BASCH E, J NATL CANC IN PRESS

[3] Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy [J].

Basch, Ethan ;

Iasonos, Alexia ;

Barz, Allison ;

Culkin, Ann ;

Kris, Mark G. ;

Artz, David ;

Fearn, Paul ;

Speakman, John ;

Farquhar, Rena ;

Scher, Howard I. ;

McCabe, Mary ;

Schrag, Deborah .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) :5374-5380

[4] Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study [J].

Basch, Ethan ;

Iasonos, Alexia ;

McDonough, Tiffani ;

Barz, Allison ;

Culkin, Ann ;

Kris, Mark G. ;

Scher, Howard I. ;

Schrag, Deborah .

LANCET ONCOLOGY, 2006, 7 (11) :903-909

[5] Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials? [J].

Bruner, Deborah Watkins .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) :5345-5347

[6] Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire [J].

Cirillo, M. ;

Venturini, M. ;

Ciccarelli, L. ;

Coati, F. ;

Bortolami, O. ;

Verlato, G. .

ANNALS OF ONCOLOGY, 2009, 20 (12) :1929-1935

[7] How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30 [J].

Fromme, EK ;

Eilers, KM ;

Mori, M ;

Hsieh, YC ;

Beer, TM .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (17) :3485-3490

[8]

Fung M, 2001, DRUG INF J, V35, P293, DOI 10.1177/009286150103500134

[9]

*NAT AC SCI I MED, 2006, FUT DRUG SAF PROM PR

[10]

Pakhomov SV, 2008, AM J MANAG CARE, V14, P530

← 1 2 →